Clinical research organization ICON plc (NASDAQ:ICLR) stock is surging on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2025 sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback